Marschner recently joined Affimed from Merck KGaA. He has 18 years of professional experience in clinical development with a focus on biological compounds.
Affimed Therapeutics Appoints Jens-Peter Marschner as Chief Medical Officer
Marschner recently joined Affimed from Merck KGaA. He has 18 years of professional experience in clinical development with a focus on biological compounds.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
